John Poulos
Director/Board Member chez FARON PHARMACEUTICALS OY
Fortune : 17 370 $ au 31/03/2024
Profil
Mr. John Poulos is an Independent Non-Executive Director at Faron Pharmaceuticals Oy and a President at GNK Advisors, Inc. He is on the Board of Directors at Memgen, Inc. and Faron Pharmaceuticals Oy.
Mr. Poulos was previously employed as a VP, Head-Business Development & Acquisitions by AbbVie Oy and a Head-Pharmaceutical Licensing & Acquisitions by Abbott Pharmaceutical, Inc. He received his undergraduate degree from Indiana University and an MBA from Indiana University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
FARON PHARMACEUTICALS OY
0,01% | 27/10/2023 | 10 000 ( 0,01% ) | 17 370 $ | 31/03/2024 |
Postes actifs de John Poulos
| Sociétés | Poste | Début |
|---|---|---|
| FARON PHARMACEUTICALS OY | Director/Board Member | 16/05/2017 |
Memgen, Inc.
 Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Director/Board Member | 18/11/2020 |
| GNK Advisors, Inc. | President | 01/01/2017 |
Anciens postes connus de John Poulos
| Sociétés | Poste | Fin |
|---|---|---|
AbbVie Oy
 AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland. | Corporate Officer/Principal | 01/01/2016 |
| Abbott Pharmaceutical, Inc. | Corporate Officer/Principal | 01/01/2012 |
Formation de John Poulos
| Indiana University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| FARON PHARMACEUTICALS OY | Health Technology |
| Entreprise privées | 4 |
|---|---|
Memgen, Inc.
Memgen, Inc. Pharmaceuticals: MajorHealth Technology Memgen, Inc. operates as a clinical-stage biotech company. Its product ISF35, is a viral cancer immunotherapy encoding an optimized version of CD40 ligand. The company was founded by Robert C. Coates and is headquartered in Houston, TX. | Health Technology |
| Abbott Pharmaceutical, Inc. | |
AbbVie Oy
AbbVie Oy Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., AbbVie Oy is a Finnish company that manufactures and wholesales pharmaceutical products. The private company is based in Espoo, Finland. | Health Technology |
| GNK Advisors, Inc. |
